T3-Parkinson's Disease Medications-MJ Flashcards

1
Q

What are the cardinal symptoms of Parkinson’s?

A

Tremor
Rigidity
Postural instability
Slowed movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tremor, rigidity, postural instability, and slowed movements are all motor muscular symptoms of Parkinson’s. What are some “other symptoms”?

A

Depression
Psychosis
Eventually leads to dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does Parkinson’s disease eventually lead to?

A

Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 5 early symptoms of Parkinson’s?

A
Decreased smell
Increase salivation
Clumsiness of hands
Micrographia
Decrease voice volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is micrographia?

A

Small handwriting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pathophysiology of Parkinson’s?

A

The substantia nigra (black substance) is part of the EPS. The substantia nigra is the part that is broken. Neurons from this region release DOPAMINE to another part. So when the substantia nigra is broken/dying, there is DECREASED dopamine and INCREASE acetycholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are possible treatment options for Parkinson’s?

A

Increase dopamine
Decrease Ach levels
Or try doing both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some of the challenges when trying to treat Parkinson’s?

A

“off times”
Drug-induced dyskinesias (ticks)
Loss of effect (the wear off)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does “off time” mean when referring to Parkinson’s treatment?

A

The drug randomly stops working for a period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the major drug classes for Parkinson’s?

A

Levodopa/carbidopa
Dopamine agonists
MOA-B inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why can’t we just give dopamine to the patient with Parkinson’s when that is all they need?

A

Dopamine can’t cross BBB easily, and even if it could it has a short half life!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does dopamine cross BBB easily?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does dopamine have a long or short half life?

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Levodopa: Can this drug cross the BBB?

A

Yes!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Levodopa: What happens when levodopa crosses the BBB into the CNS?

A

Levodopa is accepted into dopaminergic receptors where it gets converted into dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why do we have to add Carbidopa with levodopa?

A

Once levodopa is converted to dopamine, it can spread into the periphery. Adding carbidopa allows this to not happen as much. This keeps the dopamine in the brain (where we want it), which allows us to decrease the dose, which in turn, decreases the side-effects (cardiovascular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How effective is the levodopa/carbidopa combo?

A

VERY; there is a 50% reduction in Parkinson’s symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T or F: Levodopa/carbidopa combo is so effective that if a client doesn’t respond, maybe they don’t have Parkinson’s. Maybe they were mis-diagnosed.

A

TRUE

19
Q

How long does it take for the levodopa/carbidopa combo to work?

A

Several months before it reaches full effect!

After 5 years or so, the drug won’t work anymore. It does not last forever

20
Q

What are the major side-effects of the levodopa/carbidopa combo?

A
N/V
Dyskinesias
Postural hypotension
Dyshrythmias
Impulse control
21
Q

Levodopa/carbidopa: N/V

What happens if the patient is experiencing a lot of N/V. What can we suggest?

A
  1. Suggest to the patient to talk to their prescriber about temporalrly lowering their dose until their bodies adjust
  2. Take the drug with a LOW protein snack
22
Q

Levodopa/carbidopa: N/V

Why should the patient take low protein snack instead of high?

A

Low protein will slow down the absorption so N/V will decrease. Taking too much protein will cause competion with the levodopa and slows the transport of levodopa through the BBB

23
Q

Levodopa/carbidopa: Dyskinesias

What can we suggest to the patient if they are experiencing too much of this?

A

Tell them they may need to talk to their provider about lowering their dose

24
Q

Levodopa/carbidopa: Postural hypotension

What should we suggest to the patient if they are experiening this?

A

Tell them the importance of increasing sodium and water levels. This will add more fluid to the vascular space, so the patient doesn’t get dizzy when they stand

25
Q

Levodopa/carbidopa: Why do Parkinson’s patients have similar symptoms to schizophrenic patients?

A

Schizophrinic patients are thought to have problems due to increase dopamine. Having the lev/car combo may add more dopamine than we want and that can cause some psychosis symptoms

26
Q

Can we give an antipsychotic to a patient with Parkinsons? Antipsychotics block dopamine??

A

Yes, we can. But only certain kinds!

27
Q

Why can’t we give a first generation antipsychotic to help treat psychosis symptoms?

A

They will block too much dopamine

28
Q

What antipsychotic drugs can we give to help treat the psychosis symptoms without it having major interactions?

A

Second generation antipsychotics!

Clozapine (remember agranulocytosis) and Quetiapine

29
Q

What are the three major interactions when giving levodopa/carbidopa combo?

A
  1. First generation antipsychotics
  2. MAOI
  3. High protein meals
30
Q

Why can’t we give a MAOI when giving the lev/car combo?

A

Way too much dopamine; MAOI will totally prevent the destruction of dopamine causing levels to increase too high

31
Q

Why can’t patients eat high protein meals when taking the lev/car combo?

A

Protein competes with levodopa and slows the transport of levodopa through the BBB

32
Q

What is the patient education we should give when talking about the lev/car combo mixed with protein?

A

It is still important to have adequate protein in the diet but instead of eating high protein meals, spread out the daily protein evenly throughout the day

33
Q

Dopamine agonists: These aren’t dopamine drugs, but they activate ______ receptors.

A

Dopamine

34
Q

What are the pros of dopamine agonists?

A
  1. No enzyme issue
  2. No dietary protein interactions
  3. Fewer dyskinesias
35
Q

What are the cons of dopamine agonists?

A
  1. Not as effective (as lev/car)
  2. Hallucinations
  3. Daytime sleepiness
  4. Postural hypotension
36
Q

What are the two kinds of dopamine agonists?

A

Ergot derived

Nonergot derived

37
Q

Dopamine agonists: Which is better–ergot derived or nonergot derived. Why?

A

Nonergot derived; they are more selective–they activate fewer receptors

38
Q

What are the dopamine agonists UNUSUAL SIDE-EFFECTS?

A

Impulse control disorders!

39
Q

Dopamine agonists unusual side-effects: What are some examples and what should we teach the patient?

A

Gambling, shopping, hyper sexuality

This usually occurs after 9 months of treatment. If a patient already has problems with this, it is IMPORTANT for them to understand this unusual side-effect.

Patient education about this to the family and patient MUST BE KNOWN

40
Q

What do MOA-B inhibitors do?

A

Increase dopamine

41
Q

What is the example of the MOA-B inhibitor given in the PPT?

A

Selegiline

42
Q

MOA-B: Why is selegiline good?

A

Very low risk of hypertensive crisis (what we usually would see with MAOIs)

43
Q

MOA-B: What is the main side effect of selegiline?

A

Insomnia

44
Q

MOA-B: If a younger patient is diagnosed with Parkinson’s, why may we start them on selegiline instead of one of the other drugs?

A

There is some thought that selegiline protects some of the neurons in the brain that are being attacked. There is no evidence to support this. but there is a CHANCE that there may be some neuroprotection so we start them on this one just in case there is neuroprotection